Usage of silver nanoparticles to restore Moxifloxacin efficacy for fluoroquinolone-resistant M.tuberculosis cultures.
10.02 - Tuberculosis and non-tuberculous mycobacterial diseases(2022)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
10.02 - Tuberculosis and non-tuberculous mycobacterial diseases(2022)